National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:
“The biggest barrier to curing cancer is no longer just the science. It’s how we fund and translate it.
That was the message NFCR President and CEO Dr. Sujuan Ba brought to the Venture Philanthropy for Vaccines panel at the World Vaccine Congress in Washington, D.C. this week – and it’s one that sits at the heart of everything NFCR has built over the past 50 years.
There is a well-documented gap in the innovation ecosystem, the ‘Valley of Death’, where a breakthrough is too advanced for grants but too early for venture capital. It’s where too many transformative ideas stall. The AIM-HI Accelerator Fund was built to close it.
AIM-HI operates as more than a fund. It’s a platform that brings together entrepreneurs, funders, business leaders, and scientific experts – because innovation doesn’t fail only from lack of capital. It fails from lack of alignment.
Philanthropy and investment are not competing priorities. When aligned with science and leadership, they become the infrastructure that moves cures to patients who are waiting today.”
Other articles about NFCR on OncoDaily.